Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)

v3.21.1
Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Disaggregation of Revenue [Line Items]    
Total revenue $ 55,150 $ 33,161
Royalties    
Disaggregation of Revenue [Line Items]    
Total revenue 7,112 6,565
Kyprolis    
Disaggregation of Revenue [Line Items]    
Total revenue 4,287 4,405
Evomela    
Disaggregation of Revenue [Line Items]    
Total revenue 2,333 1,576
Other    
Disaggregation of Revenue [Line Items]    
Total revenue 492 584
Captisol    
Disaggregation of Revenue [Line Items]    
Total revenue 31,272 21,109
Contract revenue    
Disaggregation of Revenue [Line Items]    
Total revenue 16,766 5,487
Service Revenue    
Disaggregation of Revenue [Line Items]    
Total revenue 5,462 3,357
License Fees    
Disaggregation of Revenue [Line Items]    
Total revenue 1,043 975
Milestone    
Disaggregation of Revenue [Line Items]    
Total revenue 8,417 334
Other    
Disaggregation of Revenue [Line Items]    
Total revenue $ 1,844 $ 821